Author

Julia Guez-Haddad

Bar-Ilan University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:development & morphogenesis· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:protein structure· 1

Frequent Co-Authors

Amit TzuriD· 1 shared Danit WassermaniD· 1 shared Guy NimrodiD· 1 shared Inbal SheriD· 1 shared Jordan H. ChilliD· 1 shared Michael J. EmanueleiD· 1 shared Nasrin Qassem· 1 shared Nevet Zur Biton· 1 shared

Activity by Year

2023-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Amit TzurORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cdk1 and PP2A constitute a molecular switch controlling orderly degradation of atypical E2Fs

Sapir Nachum, Noy Gamliel, Danit Wasserman, Nasrin Qassem, Inbal Sher, Julia Guez-Haddad, Michael J. Emanuele, Jordan H. Chill, Amit Tzur

The paper identifies Cdk1 and PP2A as a molecular switch that controls the degradation of E2F7 and E2F8, ensuring timely transcriptional reprogramming during the cell cycle.

Molecular Biology of the Cell · Aug 12, 2026Peer-reviewedCell Biology

Computational Engineering of a Therapeutic Antibody to Inhibit Multiple Mutants of HER2 Without Compromising Inhibition of the Canonical HER2

Sapir Peled, Julia Guez-Haddad, Nevet Zur Biton, Guy Nimrod, Sharon Fischman, Yair Fastman, Yanay Ofran

The paper designs a multi-specific antibody that retains Pertuzumab's function while inhibiting multiple HER2 mutants, showing effectiveness against S310Y, S310F, and wild-type HER2.

bioRxiv · Jul 21, 2023 · PreprintBioinformatics